EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Assessment of Dosing Strategies for Pediatric Drug Products

Zachary L Taylor iD, Francis G Green, Nayeem Hossain, Gilbert J Burckart iD, Michael Pacanowski, Robert N Schuck iD

Clinical Pharmacology & Therapeutics · 2024

DOI: 10.1002/cpt.3250 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Pharmacology & Therapeutics, 2024. Verfasst von Zachary L Taylor und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA. Hauptthemen laut MEDLINE: Antipsychotic Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural FDA HHS, NICHD NIH HHS, National Institute of Child Health and Development T32 Cincinnati Pediatric Clinical Pharmacology Training Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pediatric drug dosing is challenged by the heterogeneity of developing physiology and ethical considerations surrounding a vulnerable population. Often, pediatric drug dosing leverages findings from the adult population; however, recent regulatory efforts have motivated drug sponsors to pursue pediatric‐specific programs to meet an unmet medical need and improve pediatric drug labeling. This paradigm is further complicated by the pathophysiological implications of obesity on drug distribution and metabolism and the roles that body composition and body size play in drug dosing. Therefore, we sought to understand the landscape of pediatric drug dosing by characterizing the dosing strategies from drug products recently approved for pediatric indications identified using FDA Drug Databases and analyze the impact of body size descriptors (age, body surface area, weight) on drug pharmacokinetics for several selected antipsychotics approved in pediatric patients. Our review of these pediatric databases revealed a dependence on body size‐guided dosing, with 68% of dosing in pediatric drug labelings being dependent on knowing either the age, body surface area, or weight of the patient to guide dosing for pediatric patients. This dependence on body size‐guided dosing drives the need for special consideration when dosing a drug in overweight and obese patients. Exploratory pharmacokinetic analyses in antipsychotics illustrate possible effects of drug exposure when applying different dosing strategies for this class of drugs. Future efforts should aim to further understand the pediatric drug dosing and obesity paradigm across pediatric age ranges and drug classes to optimize drug development and clinical care for this patient population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antipsychotic AgentsHumansChildDrug Dosage CalculationsAge FactorsDrug LabelingChild, PreschoolUnited StatesAdolescentInfantBody Surface AreaBody WeightUnited States Food and Drug AdministrationDose-Response Relationship, DrugDatabases, Pharmaceutical

Substanzen

Antipsychotic Agents

Autor:innen und Institutionen

  • Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.

ORCID-Profile: Zachary L Taylor, Gilbert J Burckart, Robert N Schuck

Förderung

  • Intramural FDA HHS
  • NICHD NIH HHS
  • National Institute of Child Health and Development T32 Cincinnati Pediatric Clinical Pharmacology Training Program

Zitieren

APA

Taylor, Z. L., Green, F. G., Hossain, N., Burckart, G. J., Pacanowski, M., & Schuck, R. N. (2024). Assessment of Dosing Strategies for Pediatric Drug Products. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.3250

Vancouver

Taylor ZL, Green FG, Hossain N, Burckart GJ, Pacanowski M, Schuck RN. Assessment of Dosing Strategies for Pediatric Drug Products. Clinical Pharmacology & Therapeutics. 2024. doi:10.1002/cpt.3250

BibTeX
@article{Taylor2024,
  author = {Taylor, Zachary L and Green, Francis G and Hossain, Nayeem and Burckart, Gilbert J and Pacanowski, Michael and Schuck, Robert N},
  title = {Assessment of Dosing Strategies for Pediatric Drug Products},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2024},
  doi = {10.1002/cpt.3250}
}
Kostenlos starten →